A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and ...
Background Stillbirth rates remain unacceptably high in low- and middle-income countries (LMICs). Understanding the causes of ...
In some of the Asian-populated areas, many Asians are gathering and digging out okra, a finger-shaped vegetable, from full ...
A new Galleri blood test detected 75% of cancers without current screening options, with over half found in early stage I or ...
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers ...
A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...
Heal Squad' podcast host Maria Menounos, whose pancreatic cancer was discovered early enough to be treated, says, "If it ...
A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...
A blood test for more than 50 types of cancer could help speed up diagnosis, according to a new study. Results of a trial in North America show that the test was able to identify a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback